Blog

Schoolboy’s campaign reaches the corridors of power

Schoolboy’s campaign reaches the corridors of power
Posted on 8 Feb 2016 by Enviva Care

A plucky schoolboy battling a muscle-wasting condition recently met with one of the UK’s most senior politicians, helping to highlight the plight of many fellow sufferers. Nine-year-old Michael Young visited the Scottish First Minister Nicola Sturgeon as part of a


GPs must continue to treat care home residents

GPs must continue to treat care home residents
Posted on 4 Feb 2016 by Enviva Care

Doctors specialising in the care of older patients are urging GPs to continue to service care homes and have warned the British Medical Association (BMA) against their members treating the 400,000 patients in residential care differently to other patients. The


Exposure to algae toxin increases the risk of neurological problems

Exposure to algae toxin increases the risk of neurological problems
Posted on 2 Feb 2016 by Enviva Care

A poisonous toxin found in freshwater lakes and reservoirs across Britain could be fuelling the country’s dementia epidemic, scientists fear. Researchers have found the first direct evidence that a chemical, produced by algae, might be linked to a range of


Celebrity backing for charity’s dementia campaign

Celebrity backing for charity’s dementia campaign
Posted on 1 Feb 2016 by Enviva Care

An award-winning actress has said that arts venues have a responsibility to make provision for people suffering with dementia. Vicky McClure, who has appeared in hit dramas including This is England, Broadchurch and Line of Duty, has given her support


Epilepsy drug could protect nerves from damage in multiple sclerosis

Epilepsy drug could protect nerves from damage in multiple sclerosis
Posted on 26 Jan 2016 by Enviva Care

A drug used to treat epilepsy may also help prevent nerve damage which causes blurred vision in multiple sclerosis sufferers. Phenytoin, one of the oldest and most commonly prescribed epilepsy drugs, protected neural tissue in patients with optic neuritis. Optic


Family of cerebral palsy sufferer angered by break-in

Family of cerebral palsy sufferer angered by break-in
Posted on 25 Jan 2016 by Enviva Care

A Hampshire family were dealt a crushing blow this month after discovering the car which was specially modified to transport their teenage son had been broken into. The vehicle has been adapted to meet the needs of 14-year-old Jack Sennatt,


Alzheimer’s symptoms helped by marijuana oil

Alzheimer’s symptoms helped by marijuana oil
Posted on 21 Jan 2016 by Enviva Care

New research has found that administering cannabis extracts containing tetrahydrocannabinol (THC) to Alzheimer’s patients helped to relieve various symptoms of dementia, including agitation, aggression, apathy and delusions. The trial, conducted by Israeli researchers, studied 11 Alzheimer’s patients who were given


Dementia drug may lower risk of falls among Parkinson’s patients

Dementia drug may lower risk of falls among Parkinson’s patients
Posted on 19 Jan 2016 by Enviva Care

Scientists have discovered a commonly prescribed drug may provide a crucial lifeline for those suffering from Parkinson’s disease. Bone-breaking injuries suffered by people with Parkinson’s disease could be reduced by giving patients the “breakthrough” medication rivastigmine. Researchers found the drug


Wallace and Gromit creators produce film to raise awareness of dementia

Wallace and Gromit creators produce film to raise awareness of dementia
Posted on 18 Jan 2016 by Enviva Care

An award-winning British studio has made a short film which aims to tackle misconceptions surrounding dementia. Aardman Animations, known for creations including Wallace and Gromit and Shaun the Sheep, made the 90 second production to demonstrate how conditions such as


Cholesterol medication identified as possible Parkinson’s disease treatment

Cholesterol medication identified as possible Parkinson’s disease treatment
Posted on 14 Jan 2016 by Enviva Care

Simvastatin, which is a commonly prescribed medication for individuals with high cholesterol, is the subject of a new clinical trial that could potentially see the drug being used as part of treatment programmes for people with Parkinson’s disease. Currently, 127,000


Navigation